Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin and Vasopressin on Social Behavior
NCT02526914Unknown
- Start
- Oct 2015
- Primary completion
- Jul 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray and vasopressin (3 arms). Primary endpoint: Preferences for competitive vs cooperative compensations and monetary allocations. Status: unknown.
02
Drugs
oxytocin nasal sprayvasopressin
Beyond the preview
Go deeper on NCT02526914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526914.